For enterprises deploying AI applications with similar read-heavy workloads and unpredictable traffic spikes, OpenAI's ...
The second batch of Commissioner's national priority vouchers (CNPVs) has been published by the FDA, and includes new GLP-1 agonists for weight-loss from Eli Lilly and Novo Nordisk and drugs for ...